From the NRC perspective, we're conducting the analysis on the options right now to assess what type of public-private partnership this would best fit underneath. We are looking at various examples and best practices, such as the U.K. Vaccines Manufacturing and Innovation Centre.
There are some examples we're looking at and we're conducting an analysis now in terms of which model could best be used for the NRC's facility going forward.